KAHN BROTHERS GROUP INC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$460M
Signature - Title
Thomas G. Kahn - President
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by KAHN BROTHERS GROUP INC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. KAHN BROTHERS GROUP INC reported 51 stock holdings with total value $460M as of Q4 2024. Top holdings included C, MRK, DIS, BMY, and BP.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 51 $460M +$35.9M -$129M -$93.2M C, MRK, DIS, BMY, BP 13F-HR 2/14/2025, 04:05 PM
Q3 2024 52 $581M +$28.8M -$144M -$115M C, MRK, BP, NYCB, BAYRY 13F-HR 11/13/2024, 11:41 AM
Q2 2024 51 $595M +$54M -$71.2M -$17.2M C, MRK, BP, GSK, NYCB 13F-HR 8/14/2024, 03:14 PM
Q1 2024 52 $674M +$59.4M -$24.5M +$34.9M AGO, MRK, C, BP, GSKXXXX 13F-HR 5/15/2024, 02:14 PM
Q4 2023 42 $635M +$7.28M -$19.4M -$12.1M AGO, MRK, NYCB, C, BP 13F-HR 2/13/2024, 10:33 AM
Q3 2023 43 $641M +$3.63M -$13.4M -$9.74M NYCB, BP, MRK, AGO, PTEN 13F-HR 11/13/2023, 04:42 PM
Q2 2023 42 $682M +$2.39M -$22.1M -$19.8M MRK, NYCB, BP, BMY, AGO 13F-HR 8/9/2023, 02:59 PM
Q1 2023 45 $695M +$8.08M -$27M -$18.9M BP, MRK, BMY, NYCB, AGO 13F-HR 5/12/2023, 10:36 AM
Q4 2022 45 $760M +$3.98M -$8.69M -$4.72M AGO, MRK, BP, PTEN, BMY 13F-HR 2/15/2023, 09:56 AM
Q3 2022 45 $642M +$14.2M -$13M +$1.19M BMY, BP, AGO, MRK, PTEN 13F-HR 11/15/2022, 09:02 AM
Q2 2022 45 $743M +$21.1M -$17.5M +$3.63M PTEN, AGO, BMY, MRK, BP 13F-HR 8/10/2022, 12:36 PM
Q1 2022 46 $788M +$142M -$14.5M +$127M PTEN, AGO, MBI, BMY, BP 13F-HR 5/2/2022, 02:12 PM
Q4 2021 42 $727M +$17.3M -$1.89M +$15.4M MBI, AGO, GSKXXXX, PFE, BP 13F-HR 1/25/2022, 08:25 AM
Q3 2021 43 $710M +$22.1M -$6.84M +$15.3M AGO, MBI, BP, NYCB, PTEN 13F-HR 11/1/2021, 10:31 AM
Q2 2021 43 $698M +$26.9M -$48.3M -$21.4M AGO, BMY, PTEN, BP, MBI 13F-HR 8/4/2021, 10:17 AM
Q1 2021 42 $646M +$5.5M -$59M -$53.5M AGO, NYCB, BMY, MBI, BP 13F-HR 5/7/2021, 02:09 PM
Q4 2020 42 $573M +$3.74M -$53.6M -$49.8M BMY, AGO, GSKXXXX, NYCB, VOXX 13F-HR 2/11/2021, 09:45 AM
Q3 2020 42 $528M +$6.62M -$43.9M -$37.3M BMY, GSKXXXX, NYCB, AGO, BP 13F-HR 11/6/2020, 08:36 AM
Q2 2020 47 $592M +$18.2M -$25.2M -$7.02M GSKXXXX, BMY, NYCB, BP, AGO 13F-HR 8/3/2020, 02:43 PM
Q1 2020 48 $547M +$1.83M -$25.6M -$23.8M GSKXXXX, BMY, NYCB, BP, AGO 13F-HR 5/11/2020, 10:16 AM
Q4 2019 46 $824M +$2.05M -$114M -$112M AGO, GSKXXXX, BMY, NYCB, BP 13F-HR 1/27/2020, 12:41 PM
Q3 2019 45 $707M +$14.8M -$11.9M +$2.97M AGO, NYCB, GSKXXXX, BP, SEB Restatement 11/5/2019, 09:40 AM
Q2 2019 42 $710M +$169M -$6.61M +$162M BP, AGO, GSKXXXX, SEB, NYCB 13F-HR 8/5/2019, 11:27 AM
Q1 2019 31 $640M +$25.2M -$43.7M -$18.5M BP, AGO, GSKXXXX, NYCB, BB 13F-HR 5/6/2019, 10:06 AM
Q4 2018 31 $555M +$7.99M -$12.5M -$4.47M BP, AGO, GSKXXXX, NYCB, MBI 13F-HR 1/29/2019, 01:33 PM
Q3 2018 31 $651M +$14.8M -$16.9M -$2.16M BP, AGO, BB, GSKXXXX, MBI 13F-HR 10/30/2018, 02:36 PM
Q2 2018 31 $628M +$12.4M -$16.6M -$4.18M BP, GSKXXXX, NYT, AGO, BB 13F-HR 8/6/2018, 10:09 AM
Q1 2018 30 $627M +$16M -$23.7M -$7.67M BP, NYT, BB, GSKXXXX, AGO 13F-HR 5/1/2018, 03:04 PM
Q4 2017 31 $637M +$16.7M -$18M -$1.29M BP, NYT, BB, GSKXXXX, AGO 13F-HR 1/25/2018, 01:34 PM
Q3 2017 33 $639M +$24.6M -$40.4M -$15.8M NYT, BP, BB, GSKXXXX, MBI Restatement 11/7/2017, 11:21 AM
Q2 2017 34 $656M +$24.7M -$28.4M -$3.76M NYT, BP, GSKXXXX, BB, MBI 13F-HR 8/8/2017, 11:52 AM
Q1 2017 33 $580M +$27.7M -$28.2M -$492K NYT, BP, GSKXXXX, HOLX, MBI 13F-HR 5/8/2017, 01:58 PM
Q4 2016 35 $592M +$32.7M -$18.3M +$14.4M NYT, BP, HOLX, MBI, NYCB 13F-HR 1/31/2017, 01:23 PM
Q3 2016 34 $552M +$15.9M -$16.8M -$864K HOLX, BP, NYT, BB, MBI 13F-HR 11/1/2016, 10:03 AM
Q2 2016 37 $517M +$11.6M -$29.2M -$17.5M NYT, BP, HOLX, PFE, NYCB 13F-HR 8/9/2016, 01:27 PM
Q1 2016 37 $534M +$9.21M -$19.7M -$10.5M NYT, HOLX, NYCB, PFE, MBI 13F-HR 5/9/2016, 10:58 AM
Q4 2015 38 $560M +$9.66M -$6.83M +$2.83M NYT, HOLX, PFE, NYCB, BB 13F-HR 2/8/2016, 09:02 AM
Q3 2015 38 $540M +$20.5M -$16.6M +$3.82M HOLX, PFE, NYCB, NYT, BP 13F-HR 11/9/2015, 11:11 AM
Q2 2015 40 $593M +$17.9M -$26.7M -$8.82M PFE, NYCB, NYT, HOLX, BP 13F-HR 7/28/2015, 10:12 AM
Q1 2015 42 $592M +$8.13M -$33.9M -$25.8M PFE, NYT, NYCB, HOLX, SEB 13F-HR 5/6/2015, 09:33 AM
Q4 2014 43 $568M +$8.55M -$40.3M -$31.7M PFE, NYT, NYCB, SEB, BP 13F-HR 2/3/2015, 09:54 AM
Q3 2014 44 $615M +$3.7M -$38.8M -$35.1M PFE, NYCB, NYT, HOLX, BP 13F-HR 11/6/2014, 09:45 AM
Q2 2014 43 $687M +$67.8M -$28.9M +$38.9M NYT, PFE, NYCB, BP, HOLX 13F-HR 8/6/2014, 02:37 PM
Q1 2014 42 $701M +$93.6M -$83.9M +$9.75M NYT, PFE, NYCB, ORI, PTEN 13F-HR 5/7/2014, 01:56 PM
Q4 2013 41 $551M NYT, PFE, NYCB, ORI, PTEN 13F-HR 2/4/2014, 12:44 PM